Viewing StudyNCT06422663



Ignite Creation Date: 2024-06-16 @ 11:47 AM
Last Modification Date: 2024-10-26 @ 3:30 PM
Study NCT ID: NCT06422663
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-06-13
First Post: 2024-03-19

Brief Title: A Study To Evaluate The Treatment Pattern Of Moderate-to-Severe Asthma Patients In China
Sponsor:
Organization: AstraZeneca

Study Design

Study Type: OBSERVATIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: False
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 500
Enrollment Type: ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Name
Case-Only
Time Perspective List:

Clinical Trial Statuses

Name
107095
Who Masked List: